Neurology
Achieving Value in Multiple Sclerosis: Expert Perspectives
The care of the multiple sclerosis (MS) patient, is optimized by providing comprehensive services across healthcare providers, through coordinated patient support programs (PSPs). This program reviews the drivers of value in MS, the benefits of coordinated care, and how the private sector/pharmaceutical manufacturers can help drive value at the patient and healthcare professional level.
This program has received an unrestricted educational grant and support from Pharmascience.
DURATION
10 min
PROFESSION
Pharmacy
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2024-03-10
The care of the multiple sclerosis (MS) patient, is optimized by providing comprehensive services across healthcare providers, through coordinated patient support programs (PSPs). This program reviews the drivers of value in MS, the benefits of coordinated care, and how the private sector/pharmaceutical manufacturers can help drive value at the patient and healthcare professional level.
This program has received an unrestricted educational grant and support from Pharmascience.
Faculty
Ahmad Abulaban, MBBS, SBN, CRND, MSCS, ABCN(CCEEG)
Yaser M. Al Malik, MD,FRCPC, American Board of Psychiatry and Neurology, CSCN (EEG & EMG)
Learning objectives
After viewing this expert brief, participants will be better able to:
- Discuss the concept of value in the context of specialty pharmaceuticals, with the focus on MS.
- Describe why patient support program (PSPs) contribute to value in in MS.
- Explain how a multimodal approach, through PSPs, can drive value and improve outcomes at the patient level.
- Describe how healthcare system level initiatives can drive value at the healthcare professional level.